AbbVie Form 144: Notice to Sell 13,000 Shares

AbbVie filed a Form 144 notice to sell 13,000 shares of common stock on 05/26/2026.

Rhea-AI Filing Summary

AbbVie filed a Form 144 notice to sell 13,000 shares of common stock on 05/26/2026. The filing lists an aggregate offering price of $2,781,990.90 and reports 1,766,792,821 shares outstanding in the same line. The broker listed is Morgan Stanley Smith Barney LLC at 1 New York Plaza, New York.

The filing identifies multiple blocks of restricted stock by grant date and share counts: 2,535 (05/06/2013), 2,764 (05/09/2014), 2,187 (05/08/2015), 2,974 (05/06/2016), and 2,540 (05/05/2017). The document is a sale notice under Form 144 and lists the NYSE as the exchange.

Insights

Securities Compliance Counsel

Form 144 lists a proposed sale of 13,000 AbbVie shares with an aggregate value of $2.78M.

The notice identifies the broker Morgan Stanley Smith Barney LLC and cites 05/26/2026. It enumerates five tranches of restricted stock by grant date and share counts, which appear to be the lots to be disposed.

Cash‑flow treatment and whether sales were executed are not stated; subsequent filings or trade reports would show completion or method of sale.

Key Figures

Shares proposed for sale: 13,000 shares Aggregate offering price: $2,781,990.90 Shares outstanding: 1,766,792,821 shares +5 more

8 metrics

Shares proposed for sale 13,000 shares Form 144 line item dated 05/26/2026

Aggregate offering price $2,781,990.90 Value shown on the filing line with the 13,000 shares

Shares outstanding 1,766,792,821 shares Number shown on the same data row as the offering

Restricted lot — 05/06/2013 2,535 shares Grant date and lot listed in 'Securities To Be Sold'

Restricted lot — 05/09/2014 2,764 shares Grant date and lot listed in 'Securities To Be Sold'

Restricted lot — 05/08/2015 2,187 shares Grant date and lot listed in 'Securities To Be Sold'

Restricted lot — 05/06/2016 2,974 shares Grant date and lot listed in 'Securities To Be Sold'

Restricted lot — 05/05/2017 2,540 shares Grant date and lot listed in 'Securities To Be Sold'

Key Terms

Form 144, Restricted Stock, Aggregate offering price, Shares outstanding

4 terms

Form 144 regulatory

"Filer Information | | | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock financial

"Common | 05/06/2013 | Restricted Stock | Issuer"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Aggregate offering price financial

"Morgan Stanley Smith Barney LLC Executive Financial Services ... | 2781990.90"

The aggregate offering price is the total dollar amount that will be raised if all the securities in an offering are sold at the stated offering price, before fees or expenses are taken out. Investors use it to gauge the size of the fundraising and its potential effects—such as how much cash the company will get and how much existing ownership might be reduced—similar to totaling every item’s price in a shopping cart to see the full bill.

Shares outstanding market

"1766792821 | 05/26/2026 | NYSE"

Shares outstanding are the total number of a company’s stock units held by all shareholders, including institutional investors and company insiders — think of them as the total number of slices of the company’s ownership pie. Investors use this number to calculate how much of the company each share represents, and it directly affects per-share measures like earnings per share, ownership percentage and valuation; when the slice count changes, an investor’s claim and the company’s per-share metrics change too.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does AbbVie's Form 144 filing report?

It reports a proposed sale of 13,000 shares of common stock with an aggregate offering price of $2,781,990.90, filed with broker Morgan Stanley Smith Barney LLC on 05/26/2026.

Which share lots are listed in the filing for ABBV?

The filing lists five restricted stock lots by grant date and counts: 2,535 (05/06/2013), 2,764 (05/09/2014), 2,187 (05/08/2015), 2,974 (05/06/2016), 2,540 (05/05/2017).

Who is the broker handling the proposed ABBV sale?

The broker listed is Morgan Stanley Smith Barney LLC, address shown as 1 New York Plaza, 8th Floor, New York, NY 10004, as provided on the Form 144 line.

Does the Form 144 confirm the shares were sold?

No. The Form 144 is a notice of a proposed sale; the filing itself does not confirm execution. Completion would appear in subsequent trade reports or filings.

What exchange is associated with this Form 144 entry for ABBV?

The filing line lists the NYSE as the exchange associated with the securities to be sold, shown on the same data row as the offering amounts.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/26/2026 - 04:10 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001448074
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ABBVIE INC.
SEC File Number	001-35565
Address of Issuer	1 North Waukegan Road North Chicago ILLINOIS 60064-6400
Phone	847-932-7900
Name of Person for Whose Account the Securities are To Be Sold	ROBERT J ALPERN
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	13000	2781990.90	1766792821	05/26/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/06/2013	Restricted Stock	Issuer			2535	05/06/2013	Not Applicable
Common	05/09/2014	Restricted Stock	Issuer			2764	05/09/2014	Not Applicable
Common	05/08/2015	Restricted Stock	Issuer			2187	05/08/2015	Not Applicable
Common	05/06/2016	Restricted Stock	Issuer			2974	05/06/2016	Not Applicable
Common	05/05/2017	Restricted Stock	Issuer			2540	05/05/2017	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	05/26/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Robert Alpern
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)